Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Filter Results By

Filter Applied. Clear All
Reset All Filters
Scholar

Donna Harrison, M.D.

Associate Scholar

Dr. Donna Harrison is a physician, board-certified in obstetrics and gynecology for 30 years. She is currently serving as Director of Research for the American Association of Pro-Life Obstetricians and Gynecologists, the largest non-sectarian pro-life physician organization in the world, with over 7,000 members across the United States, and associate members on every continent.

Dr. Harrison’s research interests include selective progesterone receptor modulators, endometrial contraception, maternal mortality, and abortion mortality and morbidity. She has authored peer reviewed papers on maternal mortality, mifepristone mortality and morbidity, the approval of mifepristone and ulipristal (Ella) as well as other topics concerning endometrial contraception. Dr. Harrison is a Continuing Medical Education Speaker in the United States and internationally on topics of Medical Abortion with Mifepristone and Misoprostol, Adverse Events associated with Mifepristone and Misoprostol, Emergency Contraception with Ulipristal, Maternal Mortality, and Abortion Morbidity.

She is an Adjunct Professor at Trinity International University in Deerfield, IL, teaching post graduate seminars at the annual Center for Bio Ethics and Human Dignity summer workshops. She is Associate Editor of the peer reviewed medical journal “Issues in Law and Medicine.”

Dr. Harrison is married to Dr. Mark Harrison, M.D., and is the mother of 5 children and 5 grandchildren.

 

Research Authored

featured-image
Maternal & Public Health

Comparative Acuity of Emergency Department Visits Following Pregnancy Outcomes Among Medicaid Eligible Women, 2004-2015

Consistent with national trends for ED visits, both the number and acuity of ED visits following pregnancy outcomes are increasing. ED visit acuity following chemical abortion is persistently and significantly higher than for surgical abortion or live birth.

featured-image
Maternal & Public Health

A Cohort Study of Mental Health Services Utilization Following a First Pregnancy Abortion or Birth

A first pregnancy abortion, compared to a birth, is associated with significantly higher subsequent mental health services utilization following the first pregnancy outcome. The risk attributable to abortion is notably higher for inpatient than outpatient mental health services.

featured-image
Maternal & Public Health

The Enduring Association of a First Pregnancy Abortion with Subsequent Pregnancy Outcomes: A Longitudinal Cohort Study

Multiple abortions are consistently associated with adverse health consequences. Prior abortion is a known risk factor for another abortion. Objective: To determine the persistence of the association of a first-pregnancy abortion with the likelihood of subsequent pregnancy outcomes.

featured-image
Maternal & Public Health

A Post Hoc Exploratory Analysis: Induced Abortion Complications Mistaken for Miscarriage in the Emergency Room are a Risk Factor for Hospitalization

Previous research indicates that an increasing number of women who go to an emergency room for complications following an induced abortion are treated for a miscarriage, meaning their abortion is miscoded or concealed.

Maternal & Public Health

Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: Unwanted Abortions, Unnecessary Abortions, Unsafe Abortions

The failure of abortion providers to support and undertake prospective longitudinal studies of a nationally representative sample of women contributes to our belief that the ideological biases of abortion providers have led to a combination of disinterest, willful ignorance, or even a conspiracy to hide the widespread dangers of unwanted and contraindicated abortions.

featured-image
Maternal & Public Health

A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015

Existing research on postabortion emergency room visits is sparse and limited by methods which underestimate the incidence of adverse events following abortion. Postabortion emergency room (ER) use since Food and Drug Administration approval of chemical abortion in 2000 can identify trends in the relative morbidity burden of chemical versus surgical procedures.

featured-image
Maternal & Public Health

Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019

Objectives: Primary: Analyze the Adverse Events (AEs) reported to the Food and Drug Administration (FDA) after use of mifepristone as an abortifacient. Secondary: Analyze maternal intent after ongoing pregnancy and investigate hemorrhage after mifepristone alone.

featured-image
Maternal & Public Health

Estimating the Period Prevalence of Mothers Who Have Abortions: A Population Based Study of Inclusive Pregnancy Outcomes

The prevalence of induced abortion among women with children has been estimated indirectly by projections derived from survey research. However, an empirically derived, population-based conclusion on this question is absent from the published literature.

featured-image
Maternal & Public Health

Estimating the Period Prevalence of Publicly Funded Abortion to Space Live Births, 1999 to 2014

Although a majority of women who have an abortion report having 1 or more children, there is no published research on the number of abortions which occur between live births, after a first child but before the last. The objectives of this research, therefore, were to estimate the period prevalence of an induced abortion separating live births in a population of Medicaid eligible enrollees and to identify the characteristics of enrollees significantly associated with the use of abortion to enable child spacing.

featured-image
Maternal & Public Health

Pregnancy Outcome Patterns of Medicaid-Eligible Women, 1999-2014: A National Prospective Longitudinal Study

The objective of this study was to describe the characteristic patterns of subsequent pregnancy outcomes evolving from each of three initiating outcome events (birth, induced abortion, natural fetal loss) occurring in a Medicaid population fully insured for all reproductive health services.